sb.scorecardresearch
Advertisement

Published 17:03 IST, November 24th 2020

Russia's 'Sputnik V' COVID-19 vaccine shows over 91.4% efficacy as per interim trial data

The world’s first COVID-19 vaccine to be registered, Russia’s Sputnik V, has announced its efficacy to be 91.4% based on the interim analysis of Phase 3 trials.

Reported by: Aanchal Nigam
Follow: Google News Icon
  • share
COVID-19
null | Image: self
Advertisement

Loading...

17:03 IST, November 24th 2020